Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Lung neuroendocrine tumors account for 25% of all neuroendocrine tumors. It is a heterogeneous group that meets morphological criteria; immunohistochemical and molecular; defining 4 groups: Typical and atypical carcinoid tumors, neuroendocrine carcinomas with large cell and small cells. Carcinoid syndrome is rare in these tumors and the treatment is based on surgery for localized forms and multimodal treatment for metastatic forms.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Kehili H, Bengueddach A, Kaid M, Allaoui M, Benabdellah H,
Keywords: lung neuroendocrine tumors, rare, prognosis,
Introduction: Development of carcinoid heart disease (CHD) is the major negative prognostic factor in patients with the carcinoid syndrome. The only effective treatment is valve replacement. However, the selection of candidates and determination of optimal timing remain unclear. Considerable variability in local treatment strategies exist
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Bousahba A,
Keywords: carcinoid heart disease, somatostatin analogue, neuroendocrine tumors,
Introduction: Neuro docrine tumors are poorly known and infrequent tumors are, most of the time, diagnosed late, often occurring between the age of 40 and 60.They mainly appear in the gastro intestinal system, pancreas, bronchi, lungs, thymus and thyroid.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Bengueddach A, Kehili H, Negadi S, Yamouni M, Malika K,
Keywords: Neuroendocrine tumors, metastasis, somatostatin analogs,